Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: Alloengraftment with potential preservation of fertility in women

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1049-1055

  Singhal, S ^a   Powles, R ^a   Treleaven, J ^a   Horton, C ^a   Swansbury, G J ^a   Mehta, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acute leukemia; Allogeneic bone marrow transplantation; Engraftment; Fertility; Graft rejection; Melphalan; Pregnancy; Total body irradiation

Indexed keywords

MELPHALAN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CHILD; CHIMERA; CLINICAL ARTICLE; DONOR; FEMALE; FEMALE FERTILITY; GRAFT FAILURE; HEMATOPOIESIS; HLA SYSTEM; HUMAN; LYMPHOBLASTOMA; MALE; MORTALITY; PREGNANCY RATE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SIBLING; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HUMANS; INFERTILITY, FEMALE; MALE; MELPHALAN; NUCLEAR FAMILY; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0030443703     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Martin PJ. Determinants of engraftment after allogeneic marrow transplantation. Blood 1992; 79: 1647-1650.
2. Mehta, J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583-587.
3. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation. New Engl J Med 1975; 292: 832-843, 895-902.
4. Powles RL, Clink HM, Spence D et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1: 327-329.
5. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Engl J Med 1983; 309: 1347-1353.
6. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
7. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
8. Spitzer TR, Peters C, Ortlieb M et al. Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int J Radiat Oncol Biol Phys 1994; 29: 39-44.
9. Slavin S, Naparstek E, Aker M et al. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant Proc 1989; 21: 3053-3054.
10. Or R, Mehta J, Kapelushnik J et al. Total lymphoid irradiation, anti-lymphocyte globulin and Campath I-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection. Bone Marrow Transplant 1994; 13: 97-99.
11. Przepiorka D, Dimopoulos M, Smith T et al. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marow transplantation: risk factors for early regimen-related toxicity. Ann Hematol 1994; 68: 183-188.
12. Mehta J, Powles R, Singhal S et al. T cell depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. Bone Marrow Transplant 1996; 17: 881-883.
13. Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983; 1: 612-615.
14. Powles R, Pedrazzini A, Crofts M et al. Mismatched family bone marrow transplantation. Semin Hematol 1984; 21: 182-187.
15. Mehta J, Powles R, Horton C et al. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 1994; 14: 415-418.
16. Milliken S, Powles R, Parikh P et al. Successful pregnancy following bone marrow transplantation for leukaemia. Bone Marrow Transplant 1990; 5: 135-137.
17. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database: structure and description. Bone Marrow Transplant 1996; 17 (Suppl. 1): S140 (Abstr.).
18. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database for use in routine care and clinical research. Bone Marrow Transplant 1996; 17 (Suppl. 1): S55 (Abstr.).
19. Selby PJ, Lopes N, Mundy J et al. Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy. Br J Cancer 1987; 55: 531-533.
20. Mehta J, Powles R, Horton C et al. The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995; 15: 853-858.
21. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
22. Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 1988; 72: 555-561.
23. Van Besien K, Demuynck H, LeMaistre CF et al. High-dose melphalan allows durable engraftment of allogeneic bone marrow. Bone Marrow Transplant 1995; 15: 321-323.
24. Appelbaum FR, Fefer A. The pathogenesis of aplastic anemia. Semin Hematol 1981; 18: 241-257.
25. Helenglass G, Powles RL, McElwain TJ et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant 1988; 3: 21-29.
26. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
27. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
28. Singhal S, Powles R, Treleaven J et al. Comparison of cell yields in a double-blind randomized study of allogeneic marrow versus blood stem cell transplantation. Bone Marrow Transplant 1996; 17 (Suppl. 1): S117.
29. Mehta J. Graft-versus-leukemia reactions in clinical bone marrow transplantation. Leuk Lymphoma 1993; 10: 427-432.
30. Mehta J, Powles R, Singhal S et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants. Bone Marrow Transplant 1996; 17 (Suppl. 1): S22 (Abstr. 133).
31. Mehta J, Powles R, Singhal S et al. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 133-137.
32. Bearman SI, Appelbaum FR, Back A et al. Regimen-related toxicity and early post-transplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 1989; 7: 1288-1294.
33. Deeg HJ. Delayed complications and long-term effects after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 641-657.
34. Apperley JF, Rio B, Ljungman P, Kolb HJ. Outcome of conceptions in recipients of autologous and allogeneic transplants. Blood 1995; 86 (Suppl. 1): 399a (Abstr.).
35. Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
36. Mehta J, Powles R, Singhal S et al. Sequential high-dose therapy of adult acute lymphoblastic leukemia: role of maintenance chemotherapy after peripheral blood stem cell transplantation in first remission. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation: Proc Seventh Int Symp, Arlington, Texas. The Cancer Treatment Research and Educational Institute: Arlington, 1995, pp. 135-144.
37. Mehta J, Powles R, Singhal S et al. Consolidation therapy of adult acute lymphoblastic leukemia: role of sequential auto and allografting. Blood 1995; 86 (Suppl. 1): 384a (Abstr).
38. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.